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Background: Acute superior mesenteric artery occlusion is a life-threatening disease that 
often has nonspecific symptoms. However, it should be suspected in those with known risk 
factors such as atrial fibrillation, cardiac thrombus or cardiac valvular disease. 
Case Report: We reported two cases of acute thromboembolic occlusions of superior 
mesenteric artery that developed in acute cerebral infarction patients with confirmed atrial 
fibrillation.
Conclusions: Nonspecific symptoms of acute superior mesenteric artery occlusion should 
be closely monitored in acute cerebral infarction patients with atrial fibrillation, considering 
significance of early management of both vascular disease entities.
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INTRODUCTION
Acute intestinal ischemia by superior mesenteric artery 
(SMA) occlusion is a life-threatening disease that requires 
rapid management. Without early diagnosis and manage-
ment to restore mesenteric blood flow, SMA occlusion 
causes extensive bowel necrosis, resulting in a poor prog-
nosis with a high mortality rate up to 80%.1,2
Since clinical signs and symptoms of acute SMA occlu-
sion are often nonspecific, careful examination and close 
monitoring is required especially for patients with altered 
mental status or language function impairment. Risk fac-
tors for SMA occlusion include atrial fibrillation, cardiac 
valvular disease, infective endocarditis, or peripheral vascu-
lar disease, which are also known as risk factors of cerebral 
infarction. A previous study reported a case of SMA occlu-
sion in patient with atrial fibrillation history who was sub-
sequently diagnosed with acute infarction.3 Earlier autopsy 
findings of SMA occlusion patients have shown that 2.3% 
of the patients has concurrent presence of acute ischemic 
stroke,4 while the incidence of SMA occlusion in the isch-
emic stroke patients is unknown. Early study reported sev-
eral cases, in which acute cerebral infarction patients with 
atrial fibrillation suffered from mesenteric ischemia. How-
ever, courses of management were limited due to patient’s 
early death5 or refusal of further intervention.6 
Herein, we presented two cases of acute thromboem-
bolic SMA occlusion that developed in patients who were 
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hospitalized for acute cerebral infarction with known atrial 
fibrillation.  
CASE REPORT   
Case 1
An 85-year-old woman with a history of hypertension, 
diabetes mellitus and Parkinson disease was referred to our 
hospital with sudden right-sided weakness. She had not 
taken any antithrombotic drugs. Neurological examination 
revealed left gaze preference, right-sided hemianopsia, 
aphasia and weakness in the right face and extremities. 
Diffusion weighted image (DWI) indicated high signal in-
tensities in left middle cerebral artery (MCA) territory and 
magnetic resonance angiography (MRA) showed left proxi-
mal MCA occlusion (Fig. 1A, B). Initial electrocardiogram 
showed atrial fibrillation with rapid ventricular response 
with a pulse rate of 134/min. Fibrinogen was 486 mg/dL 
(normal range, 200-400 mg/dL), and B type natriuretic 
peptide was 560.7 pg/mL (normal range, 0-100 pg/mL). 
Her transthoracic echocardiogram showed enlarged left 
atrium with preserved global systolic function with 50% of 
ejection fraction, and mild global hypokinesia of left ventri-
cle. Twenty-four-hour Holter monitoring confirmed persis-
tent atrial fibrillation with a maximum pulse rate of 213/
Figure 1. (A) Diffusion-weighted MRI shows diffusion restriction in the left middle cerebral artery territory. (B) MR angiography shows 
occlusion (arrow) of left proximal middle cerebral artery. (C) Brain non-contrast CT shows hemorrhagic transformation in the left mid-
dle cerebral artery territory. (D) DWI shows diffusion restriction in the right MCA territory. (E) MR angiography shows occlusion  (arrow) 
of right distal MCA. MRI, magnetic resonance imaging; CT, computed tomography; DWI, diffusion weighted image; MCA, middle ce-
rebral artery.
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min. Thyroid function test was in normal range (T3, 0.77 
ng/mL; Free T4, 1.2 ng/dL; TSH, 2.99 micro International 
units [mIU]/mL). Despite no transesophageal echocardio-
gram and evaluation for cancer marker, considering the 
absence of evidence for embolism other than atrial fibrilla-
tion, , a cardioembolic stroke due to atrial fibrillation was 
suspected. However, we did not start systemic anticoagula-
tion because of the high risk of hemorrhagic transforma-
tion in acute period, especially in large size infarction.
On the 8th hospital day, the patient complained of ab-
dominal pain and diarrhea, and the next day hematemesis 
and melena occurred. Laboratory data showed anemia, 
leukocytosis and C-reactive protein elevation (Hemoglobin, 
11.9 g/dL; Hematocrit, 34.4%; white blood cell [WBC], 
23,210/mm3; C-reactive protein, 92.3 mg/dL), and electro-
cardiogram showed atrial fibrillation with rapid ventricular 
response with a pulse rate of 160/min. Emergent gastro-
duodenoscopy revealed reflux esophagitis; and abdominal 
computed tomography (CT) scan showed diffuse mural 
thickening in ileum and ascending colon and filling defect 
in the proximal portion of the SMA main trunk (Fig. 2), 
which led to the diagnosis of acute SMA occlusion. 
Systemic anticoagulation by intravenous heparin was 
selected as the initial treatment instead of endovascular 
revascularization. Activated partial thromboplastin time 
(aPTT) was well controlled (between 60-80 seconds). Ab-
dominal symptoms were gradually improved and follow-
up abdominal CT at 12 days after anticoagulation showed 
decreased thrombus in proximal SMA. However, brain CT 
on the same day revealed hemorrhagic transformation of 
infarcted tissue (Fig. 1C). We continued systemic antico-
agulation and switched heparin to apixaban 2.5 mg twice-
daily, considering the patients’ age, body weight (53.6 kg), 
renal function (creatinine, 0.73 mg/dL), brain hemorrhagic 
transformation and nonvalvular atrial fibrillation. 
Case 2
A 75-year-old-man with a history of hypertension, per-
sistent atrial fibrillation, active tuberculosis, and hypothy-
roidism was referred to our hospital with sudden left-sided 
hemianopsia and sensory extinction. He had been taking 
warfarin for 7 years. DWI of the brain magnetic resonance 
image (MRI) showed high signal intensities in territory of 
inferior division of right MCA, and MRA showed severe ste-
nosis of right distal MCA. Initial electrocardiogram showed 
atrial fibrillation with slow ventricular response, and pulse 
rate was 46/min. Transthoracic echocardiogram showed 
enlarged left ventricle with 64% of ejection fraction, and a 
moderate atrial regurgitation due to degenerative change 
of atrial valve. Transesophageal echocardiogram and can-
cer marker evaluation was not done. His heart CT showed 
no aortic arch plaque which may have caused embolism. 
Figure 2. (A) Abdominal computed tomography scan shows filling defect (1.4 cm, arrow) in length in proximal superior mesenteric 
artery. (B) Follow up CT 12 days after anticoagulation shows decreased thrombus (0.7 cm, arrow) with partial recanalization. CT, com-
puted tomography.
A  B
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Thyroid function test (T3, 0.26 ng/mL; Free T4, 0.73 ng/
dL; TSH, 3.38 uIU/mL) indicated no thyroid disease. Fi-
brinogen was 388 mg/dL, and D-dimer was 1,004 ng/mL 
(normal range, 0-243 ng/mL). Based on these findings, we 
suspected cardioembolic cerebral infarction caused by the 
atrial fibrillation. International normalization ratio (INR) 
was 1.74, so we dosed up warfarin to reach effective anti-
coagulation.
During admission, we had difficulty in control of anti-
coagulation. In the morning on the 9th hospital day, we 
decided to further increase the dose of warfarin after de-
termining INR of 1.53, which was decreased compared to 
2.66 on the 8th hospital day. In the evening on the same 
day, he complained of acute and persistent periumbilical 
pain without abdominal distension. Bowel sound was de-
creased, but nausea or vomiting were absent. Laboratory 
data showed leukocytosis and elevated C-reactive protein 
(WBC, 15,080/mm3; Hemoglobin, 12.0 g/dL; C-reactive 
protein, 41.9 mg/dL), D-dimer was 3,015 ng/mL. Electro-
cardiogram showed atrial fibrillation with rapid ventricular 
response with a pulse rate of 135/min. Abdominal CT scan 
revealed decreased enhancement of the pelvic small bowel 
loops, without definite evidence of bowl infarction and 
suspicious intraluminal filling defect at the SMA (Fig. 3A). 
Angiography showed a thromboembolic occlusion at proxi-
mal SMA and catheter-directed thrombolysis was conduct-
ed using 100,000 International units (IU) of urokinase (Fig. 
3B). On the 10th hospital day, surgical exploration was de-
cided due to persistent abdominal pain and decreased bowl 
movement. Ischemic change was observed in a small bowel 
and in the part of transverse colon. Damaged bowel was 
resected and surgical thrombectomy was done. Follow-up 
abdominal CT scan on the 1st post-operative day showed 
persistent filling defect in the proximal SMA, and gas in 
distal arterial SMA branches and mesenteric veins, which 
indicated unresolved thrombotic occlusion in the proximal 
SMA (Fig. 3C). The 2nd-look operation was planned but 
patient’s family requested no further management. On the 
9th post-operative day, patient expired.  
DISCUSSION
SMA occlusion results in high mortality, with earlier 
studies showing rates up to 80%.1,2 Early diagnosis and 
treatment before the sign of bowel necrosis is crucial, since 
mortality increases progressively with time.7,8 Frequently, 
acute mesenteric ischemia remains unrecognized initially 
due to its non-specific symptoms.9 Once diagnosed, treat-
ment approach should be decided to restore intestinal per-
fusion as quickly as possible.10 Although it is controversial, 
recent studies show that endovascular approach such as 
catheter-directed thrombolysis, balloon angioplasty and 
stent may be as effective as surgical treatment including 
A                                                    B                                                        C
Figure 3. (A) Abdominal computed tomography scan shows filling defect (arrow) in proximal superior mesenteric artery. (B) Superior 
mesenteric angiography shows proximal SMA occlusion (arrow). (C) Follow up CT after catheter-directed thrombolysis shows gas (ar-
row) in SMA distal arterial branch and mesenteric vein. CT, computed tomography; SMA, superior mesenteric artery.
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surgical thrombectomy and resection of necrotic bowl in 
acute SMA occlusion patients.11,12
Causes of SMA occlusion include embolism from car-
diogenic sources (atrial fibrillation, cardiac thrombus or 
valvular disease), which are also reported to be associated 
with high risk for cerebral infarction. Although several 
cases were reported previously, there were limitations in 
management due to patient’s early death or refusal of 
treatment.
In the case 1, the patient was diagnosed with SMA occlu-
sion during the time she was not administered with antico-
agulation because of a risk of cerebral hemorrhagic trans-
formation. The patient in the case 2 suffered from SMA 
occlusion when under therapeutic anticoagulation. The 
timing of anticoagulation is another problem in patients 
with simultaneous cerebral infarction and SMA occlusion. 
However, it may indicate that effective anticoagulation has 
benefits in prevention and treatment of SMA occlusion in 
cerebral infarction patients with atrial fibrillation, and that 
we should carefully observe nonspecific symptoms of SMA 
occlusion especially when anticoagulation of cerebral in-
farction patients with atrial fibrillation is uncontrolled. 
In addition, atherosclerosis of aorta and its branches 
may play a role in SMA occlusion in atrial fibrillation pa-
tients. In the case 1, abdominal CT scan revealed multifocal 
calcified lesions in the abdominal aorta, and in the case 2, 
severe stenoses and chronic occlusions of ileal branch ar-
teries were shown in angiography and the lower ileum was 
perfused by collateral arteries. Considering non-specific 
symptoms, and significance of early detection and treat-
ment in acute SMA occlusion, early diagnosis and manage-
ment plan for SMA occlusion and effective anticoagulation 
are important. Also, we recommend close observation for 
gastro-intestinal symptoms and signs in cerebral infarction 
patients with atrial fibrillation.
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